MABION S.A. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.8 PLN | +4.34% |
|
+5.33% | -1.93% |
| 05-14 | Mabion S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-16 | Mabion S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MABION S.A. | Bio Therapeutic Drugs | +4.34% | +5.33% | -1.93% | +0.79% | -75.85% | 70.22M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- MAB Stock
- Charts Mabion S.A.
- Comparison Chart
